Epidermal growth factor, basic fibroblast growth factor and platelet-derived growth factor-bb can substitute for fetal bovine serum and compete with human platelet-rich plasma in the ex vivo expansion of mesenchymal stromal cells derived from adipose tissue

Cytotherapy

Volumn 13, Issue 8, 2011, Pages 933-943

  Chieregato, Katia ^a   Castegnaro, Silvia ^a   Madeo, Domenico ^a   Astori, Giuseppe ^a   Pegoraro, Maurizio ^a   Rodeghiero, Francesco ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

adipose tissue; basic fibroblast growth factor; epidermal growth factor; growth factors; mesenchymal stromal cell; platelet derived growth factor bb

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; ENDOGLIN; EOSIN; EPIDERMAL GROWTH FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; HEMATOXYLIN; HERMES ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PLATELET DERIVED GROWTH FACTOR BB; SCATTER FACTOR; SOMATOMEDIN C; THY 1 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1;

ADIPOSE TISSUE CELL; ADULT; ANTIGEN EXPRESSION; ARTICLE; BLOOD DONOR; CELL DIFFERENTIATION; CELL EXPANSION; CELL PROLIFERATION; CELL STRUCTURE; COLONY FORMING UNIT; EX VIVO STUDY; FEMALE; FETAL BOVINE SERUM; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; MESENCHYME CELL; PRIORITY JOURNAL; SERUM; STROMA CELL; THROMBOCYTE POOR PLASMA; THROMBOCYTE RICH PLASMA;

EID: 80051878794     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2011.583232     Document Type: Article

References (44)

1. Kolf CM, Cho E, Tuan RS. Mesenchymal stromal cells. Biology of adult stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther. 2007;7:204-14.
2. Bruder SP, Kurth AA, Shea M, Hayes WC, Jaiswal N, Kadiyala S. Bone regeneration by implantation of purifi ed, culture-expanded human mesenchymal stem cells. J Orthop Res. 1998;16:155-62. (Pubitemid 28249153)
3. De Kok I, Peter SJ, Archambault M, van den Bos C, Kadiyala S, Aukhil I, et al. Investigation of allogeneic mesenchymal stem cell-based alveolar bone formation: preliminary fi ndings. Clin Oral Implants Res. 2003;14:481-9. (Pubitemid 37485604)
4. Wakitani S, Goto T, Pineda SJ, Young RG, Mansour JM, Caplan AI, et al. Mesenchymal cell-based repair of large, fullthickness defects of articular cartilage. J Bone Joint Surg Am. 1994;76:579-92. (Pubitemid 24154130)
5. Awad HA, Boivin GP, Dressler MR, Smith FN, Young RG, Butler DL. Repair of patellar tendon injuries using a cellcollagen composite. J Orthop Res. 2003;21:420-31. (Pubitemid 36546808)
6. Murphy JM, Fink DJ, Hunziker EB, Burry FP. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum. 2003;48:3464-74. (Pubitemid 37531912)
7. Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5- azacytidine. Muscle Nerve. 1995;18:1417-26.
8. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res. 2004;95:9-20. (Pubitemid 38931831)
9. Kawada H, Fujita J, Kinjo K, Matsuzaki Y, Tsuma M, Miyatake H, et al. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood. 2004;104:3581-7. (Pubitemid 39564430)
10. Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA. 1999;96:10711-6. (Pubitemid 29442209)
11. Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res. 2000;61:364-70. (Pubitemid 30620221)
12. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med. 1999;5:309-13. (Pubitemid 29124367)
13. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY, et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA. 2002;99:8932-7. (Pubitemid 34693661)
14. Le Blanc K, Rasmusson I, Sundberg B, G öt herstr öm C, Hassan M, Uzunel M, et al. Treatment of severe acute graftversus- host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363:1439-41. (Pubitemid 38586721)
15. Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and cultureexpanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol. 2000;18:307-16. (Pubitemid 30056419)
16. Multicenter Clinical Trial for the Evaluation on Mesenchymal Stem Cells from Adipose Tissue in Patient with Chronic Graft versus Host Disease (CMM/EICH/2008). Available at: http:// clinicaltrials.gov
17. Treatment of refractory (acute or chronic) graft versus host disease by the infusion of expanded in vitro allogenic mesenchymal stem cell. Available at:
18. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105: 1815-22. (Pubitemid 40223708)
19. Di Nicola M, Carlo Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or non-specifi c mitogenic stimuli. Blood. 2002;99:3838-43. (Pubitemid 34534559)
20. Krampera M, Glennie S, Dyson J, Cott D, Laylor R, Simpson E, et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specifi c T cells to their cognate peptide. Blood. 2003;101:3722-9. (Pubitemid 36857965)
21. Doerr HW, Cinatl J, Sturmer M, Rabenau HF. Prions and orthopedic surgery. Infection. 2003;31:163-71. (Pubitemid 36737038)
22. Spees JL, Gregory CA, Singh H, Tucker HA, Peister A, Lynch PJ, et al. Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther. 2004;9:747-56. (Pubitemid 38660428)
23. Doucet C, Ernou I, Zhang Y, Llense JR, Begot L, Holy X, et al. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy application. J Cell Physiol. 2005;205:228-36. (Pubitemid 41428905)
24. Kocaoemer A, Kern S, Uter H, Bieback K. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells. 2007;25: 1270-8. (Pubitemid 46684887)
25. Battula VL , Bareiss PM, Treml S, Conrad S, Albert I, Hojak S, et al. Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation. 2007;75:279-91. (Pubitemid 46434949)
26. Krampera M, Pasini A, Rigo A, Scupoli MT, Tecchio C, Malpeli G, et al. HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: induced cell expansion and reversibly preventing multilineage differentiation. Blood. 2005;106:59-66. (Pubitemid 40967175)
27. Longobardi L, O'Rear L, Aakula S, Johnstone B, Shimer K, Chytil A, et al. Effect of IGF-I in the condrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF signalling. J Bone Min Res. 2006;21:626-36.
28. Solchaga LA, Penick K, Porter JD, Goldberg VM, Caplan AI, Welter JF. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol. 2005;203:398-409. (Pubitemid 40471774)
29. Tamana K, Fan VH, Griffi th LG, Blair HC, Wells A. Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells. 2006; 24:686-95. (Pubitemid 44464773)
30. Thomas T, Gori F, Spelberg TC, Khosla S, Riggs B, Conover CA. Response of biopotential human marrow stromal cells to insulin-like growth factors: effect on binding protein production, proliferation, and commitment to osteoblasts and adipocytes. Endocrinology. 1999;140:5036-44.
31. Yangxin L, XiYong Y, ShuGuang L, XiaoHong L, Saidan Z, Yao-Hua S. Insulin-like growth factor 1 enhances the migratory capacity of mesenchymal stem cells. Biochem Biophys Res Comm. 2007;356:780-4.
32. Stenderup K, Justuesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone. 2003;3: 919-26. (Pubitemid 37543568)
33. McIntyre A, Bjornson BH. Human bone marrow stromal cell colonies: response to hydrocortisone and dependence on plateletderived growth factor. Exp Hematol. 1986;14:833-9. (Pubitemid 17180035)
34. Keshavarz E, Hoare M, Dunnill P. Biochemical engineering aspects of cell disruption. In: Verrall MS, Hudson MJ. Separations for Biotechnology. Chichester: Ellis Horwood Series; 1987;34:62-79.
35. Freshney RI. Culture of Animal Cells. A Manual of Basic technique. 5th ed. Wiley-Liss Publication. New Jersey. 2005.
36. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, et al. Minimal criteria for defi ning multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315-7.
37. Storms RW, Trujillo AP, Springer JB, Shah L, Colvin OM, Ludeman SM, et al. Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci USA. 1999;96:9118-23. (Pubitemid 29374717)
38. Storms RW, Green PD, Safford KM, Niedzwiecki D, Cogle CR, Colvin OM, et al. Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34. Blood. 2005;106:95-102. (Pubitemid 40967179)
39. Christ O, Lucke K, Leung K, Hamilton M, Eaves A, Smith C, et al. Improved purifi cation of hematopoietic stem cells based on their elevated aldehyde dehydrogenase activity. Haematologica. 2007;92:1165-72. (Pubitemid 350144173)
40. Sahovic EA, Colvin M, Hilton J, Ogawa M. Role for aldehyde dehydrogenase in survival of progenitors for murine blast cellcolonies after treatment with 4-hydroperoxycyclophos phamide in vitro. Cancer Res. 1998;48:1223-6.
41. Gruber R, Karreth F, Kandler B, Fuerst G, Rot A, Fisher MB, et al. Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow derived-mesenchymal progenitor cells under in vitro conditions. Platelets. 2004;15:29-35. (Pubitemid 38283218)
42. Mitchell JB, McIntosh K, Zvonic S, Garrett S, Floyd E, Kloster A, et al. Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cellassociated markers. Stem Cells. 2006;24:376-85. (Pubitemid 44464807)
43. Im GI, Shin YW, Lee KB. Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells. Osteoarth Cart. 2005;13:845-53.
44. Hui JH, Li L, Teo YH, Ouyang HW, Lee EH. Comparative study of the ability of mesenchymal stem cells derived from bone marrow, periosteum and adipose tissue in treatment of partial growth arrest in rabbit. Tissue Eng. 2005;11:904-12. (Pubitemid 40960793)